Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 368 | 201 | 133 | 45 | -2,017 |
| Accounts receivable | -1,422 | 7,631 | -4,651 | -905 | 446 |
| Other Working Capital | -7,673 | 2,038 | -6,065 | 6,425 | -265 |
| Other Operating Activity | -26,020 | -18,340 | -10,796 | -5,170 | -2,832 |
| Operating Cash Flow | $-34,747 | $-8,470 | $-21,379 | $395 | $-4,668 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -195 | -241 | -754 | -55 | 32 |
| Investing Cash Flow | $-195 | $-241 | $-754 | $-55 | $32 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 0 | 1,000 |
| Debt Issued | N/A | N/A | N/A | 23,680 | N/A |
| Common Stock Issued | 0 | 34,568 | 25,980 | 2,099 | N/A |
| Other Financing Activity | -816 | -1,586 | -1,837 | -2,310 | 869 |
| Financing Cash Flow | $-816 | $32,982 | $24,143 | $23,469 | $1,869 |
| Exchange Rate Effect | -4 | 31 | 29 | N/A | N/A |
| Beginning Cash Position | 53,854 | 29,552 | 27,513 | 3,704 | 6,471 |
| End Cash Position | 18,092 | 53,854 | 29,552 | 27,513 | 3,704 |
| Net Cash Flow | $-35,758 | $24,271 | $2,010 | $23,809 | $-2,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,747 | -8,470 | -21,379 | 395 | -4,668 |
| Capital Expenditure | -195 | -262 | -754 | -59 | -28 |
| Free Cash Flow | -34,942 | -8,732 | -22,133 | 336 | -4,696 |